These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 23831406

  • 1. [New oral anticoagulant agents: the quandary of anticoagulation in the elderly].
    Páramo JA.
    Med Clin (Barc); 2013 Oct 19; 141(8):346-8. PubMed ID: 23831406
    [No Abstract] [Full Text] [Related]

  • 2. [New oral anticoagulants are as safe in elderly patients as conventional drugs].
    Steurer J.
    Praxis (Bern 1994); 2014 Aug 20; 103(17):1032. PubMed ID: 25146949
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis.
    Alotaibi G, Alsaleh K, Wu C, Mcmurtry MS.
    Int Angiol; 2014 Aug 20; 33(4):301-8. PubMed ID: 25056161
    [Abstract] [Full Text] [Related]

  • 7. New oral anticoagulants for acute venous thromboembolism.
    Med Lett Drugs Ther; 2014 Jan 06; 56(1433):3-4. PubMed ID: 24419296
    [No Abstract] [Full Text] [Related]

  • 8. [Atrial fibrillation: what the GP needs to know].
    Diener HC, Kaeufer T, Bode C.
    MMW Fortschr Med; 2011 Sep 22; 153(38):44-7; quiz 48. PubMed ID: 21977796
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis.
    Gómez-Outes A, Terleira-Fernández AI, Lecumberri R, Suárez-Gea ML, Vargas-Castrillón E.
    Thromb Res; 2014 Oct 22; 134(4):774-82. PubMed ID: 25037495
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
    Harenberg J, Marx S, Diener HC, Lip GY, Marder VJ, Wehling M, Weiss C.
    Int Angiol; 2012 Aug 22; 31(4):330-9. PubMed ID: 22801398
    [Abstract] [Full Text] [Related]

  • 16. Oral anticoagulation in atrial fibrillation: balancing the risk of stroke with the risk of bleed.
    Kosar L, Jin M, Kamrul R, Schuster B.
    Can Fam Physician; 2012 Aug 22; 58(8):850-8. PubMed ID: 22893338
    [No Abstract] [Full Text] [Related]

  • 17. New oral anticoagulants in the management of venous thromboembolism: a major advance?
    Sciascia S, Hunt BJ.
    Eur J Vasc Endovasc Surg; 2014 Nov 22; 48(5):487-8. PubMed ID: 25150440
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Stroke risk--atrial fibrillation].
    Dabitz R, Ochs G.
    MMW Fortschr Med; 2012 Nov 01; 154(19):53-6. PubMed ID: 23173288
    [No Abstract] [Full Text] [Related]

  • 20. [Gastrointestinal bleeding under treatment with new oral anticoagulants].
    Konturek P, Hess T.
    MMW Fortschr Med; 2014 Feb 06; 156(2):50-2. PubMed ID: 24934056
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.